Ridderstråle M - Search Results

1

Rationale, design and baseline characteristics of a 4-year (208-week) phase III trial of empagliflozin, an SGLT2 inhibitor, versus glimepiride as add-on to metformin in patients with type 2 diabetes mellitus with insufficient glycemic control.

Ridderstråle M, Svaerd R, Zeller C, Kim G, Woerle HJ, Broedl UC; EMPA-REG H2H-SU trial investigators. Ridderstråle M, et al. Cardiovasc Diabetol. 2013 Sep 5;12:129. doi: 10.1186/1475-2840-12-129. Cardiovasc Diabetol. 2013. PMID: 24007456 Free PMC article. Clinical Trial.

2

Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial.

Ridderstråle M, Andersen KR, Zeller C, Kim G, Woerle HJ, Broedl UC; EMPA-REG H2H-SU trial investigators. Ridderstråle M, et al. Lancet Diabetes Endocrinol. 2014 Sep;2(9):691-700. doi: 10.1016/S2213-8587(14)70120-2. Epub 2014 Jun 16. Lancet Diabetes Endocrinol. 2014. PMID: 24948511 Clinical Trial.

3

Comparison of Adipose Distribution Indices with Gold Standard Body Composition Assessments in the EMPA-REG H2H SU Trial: A Body Composition Sub-Study.

Neeland IJ, McGuire DK, Eliasson B, Ridderstråle M, Zeller C, Woerle HJ, Broedl UC, Johansen OE. Neeland IJ, et al. Among authors: ridderstrale m. Diabetes Ther. 2015 Dec;6(4):635-642. doi: 10.1007/s13300-015-0146-7. Epub 2015 Nov 25. Diabetes Ther. 2015. PMID: 26608511 Free PMC article.

4

Changes in HbA1c and Weight Following Transition to Continuous Subcutaneous Insulin Infusion Therapy in Adults With Type 1 Diabetes.

Mehta SN, Andersen HU, Abrahamson MJ, Wolpert HA, Hommel EE, McMullen W, Ridderstråle M. Mehta SN, et al. Among authors: ridderstrale m. J Diabetes Sci Technol. 2017 Jan;11(1):83-86. doi: 10.1177/1932296816658900. Epub 2016 Jul 11. J Diabetes Sci Technol. 2017. PMID: 27402243 Free PMC article.

5

Effect of metformin on plasma metabolite profile in the Copenhagen Insulin and Metformin Therapy (CIMT) trial.

Safai N, Suvitaival T, Ali A, Spégel P, Al-Majdoub M, Carstensen B, Vestergaard H, Ridderstråle M; CIMT Trial Group. Safai N, et al. Among authors: ridderstrale m. Diabet Med. 2018 Jul;35(7):944-953. doi: 10.1111/dme.13636. Epub 2018 May 2. Diabet Med. 2018. PMID: 29633349 Clinical Trial.

6

Stratification of type 2 diabetes based on routine clinical markers.

Safai N, Ali A, Rossing P, Ridderstråle M. Safai N, et al. Among authors: ridderstrale m. Diabetes Res Clin Pract. 2018 Jul;141:275-283. doi: 10.1016/j.diabres.2018.05.014. Epub 2018 May 19. Diabetes Res Clin Pract. 2018. PMID: 29782936

7

Correction to: Comparison of Adipose Distribution Indices with Gold Standard Body Composition Assessments in the EMPA-REG H2H SU Trial: A Body Composition Sub-Study.

Neeland IJ, McGuire DK, Eliasson B, Ridderstråle M, Zeller C, Woerle HJ, Broedl UC, Johansen OE. Neeland IJ, et al. Among authors: ridderstrale m. Diabetes Ther. 2018 Aug;9(4):1721. doi: 10.1007/s13300-018-0465-6. Diabetes Ther. 2018. PMID: 29931507 Free PMC article.

8

Empagliflozin compared with glimepiride in metformin-treated patients with type 2 diabetes: 208-week data from a masked randomized controlled trial.

Ridderstråle M, Rosenstock J, Andersen KR, Woerle HJ, Salsali A; EMPA-REG H2H-SU trial investigators. Ridderstråle M, et al. Diabetes Obes Metab. 2018 Dec;20(12):2768-2777. doi: 10.1111/dom.13457. Epub 2018 Aug 7. Diabetes Obes Metab. 2018. PMID: 29961998 Clinical Trial.

9

Estimating the impact of changes in HbA1c, body weight and insulin injection regimen on health related quality-of-life: a time trade off study.

Ridderstråle M, Evans LM, Jensen HH, Bøgelund M, Jensen MM, Ericsson Å, Jendle J. Ridderstråle M, et al. Health Qual Life Outcomes. 2016 Jan 22;14:13. doi: 10.1186/s12955-016-0411-0. Health Qual Life Outcomes. 2016. PMID: 26801908 Free PMC article.

10

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

130 results

Search Page